Allan Shapiro - Avricore Health Mang Devel
| AVCRF Stock | USD 0.06 0.01 18.36% |
Insider
Allan Shapiro is Mang Devel of Avricore Health
| Phone | 604 773 8943 |
| Web | https://www.avricorehealth.com |
Avricore Health Management Efficiency
The company has return on total asset (ROA) of (0.2745) % which means that it has lost $0.2745 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3844) %, meaning that it generated substantial loss on money invested by shareholders. Avricore Health's management efficiency ratios could be used to measure how well Avricore Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Ahmed Sabet | Precipio | 38 | |
| BBus CA | Intelligent Bio Solutions | 60 | |
| Kara Thornton | Neuronetics | N/A | |
| BSRT MPH | RadNet Inc | N/A | |
| Thomas Theuringer | Qiagen NV | N/A | |
| Ruth VilligerWilson | RadNet Inc | 60 | |
| Claire Sears | Neuronetics | N/A | |
| Gary Pestano | Biodesix | 57 | |
| Bob Halbert | Star Equity Holdings | N/A | |
| Andrew Macan | Neuronetics | 51 | |
| Ayman MD | Precipio | 39 | |
| Matthew Gage | Precipio | 57 | |
| Matthew Molchan | Star Equity Holdings | 57 | |
| Keith Meadors | Precipio | N/A | |
| David Noble | Star Equity Holdings | 54 | |
| Ranjan Jayanathan | RadNet Inc | 68 | |
| Dr III | Biodesix | 53 | |
| Martin Shirley | Star Equity Holdings | 62 | |
| Ryan Siurek | Biodesix | 52 | |
| Matt Stauffer | Biodesix | N/A | |
| Miri ChikoRadomski | Precipio | N/A | |
Management Performance
| Return On Equity | -0.38 | |||
| Return On Asset | -0.27 |
Avricore Health Leadership Team
Elected by the shareholders, the Avricore Health's board of directors comprises two types of representatives: Avricore Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avricore. The board's role is to monitor Avricore Health's management team and ensure that shareholders' interests are well served. Avricore Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avricore Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rodger Seccombe, Head Director | ||
| Hector Bremner, CEO Director | ||
| Will Seccombe, Communications Advisor | ||
| CPA CFO, CFO Sec | ||
| Allan Shapiro, Mang Devel |
Avricore Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Avricore Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.38 | |||
| Return On Asset | -0.27 | |||
| Profit Margin | (0.95) % | |||
| Operating Margin | (1.23) % | |||
| Current Valuation | 21.9 M | |||
| Shares Outstanding | 98.62 M | |||
| Shares Owned By Insiders | 8.58 % | |||
| Price To Book | 14.51 X | |||
| Price To Sales | 28.37 X | |||
| Revenue | 122.81 K |
Currently Active Assets on Macroaxis
Other Information on Investing in Avricore Pink Sheet
Avricore Health financial ratios help investors to determine whether Avricore Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Avricore with respect to the benefits of owning Avricore Health security.